COVID-19 Enfeksiyonu Sonrası Gelişen Telogen Effluvium: Vaka Sunumu

Abstract

COVID-19 enfeksiyonu sonrası döneme ilişkin bilgiler henüz netlik kazanmadı. COVID-19 sonrası belirtilere her gün bir yenisi ekleniyor. Saç dökülmesi birçok hastalığın klinik semptomlarında görülebildiği gibi hastalık geçtikten sonra da görülebilmektedir. Telogen effluvium (TE), bir stres etkeninden yaklaşık 3-4 ay sonra ortaya çıkan yaygın saç dökülmesi ile karakterize bir durumdur. Bu yazıda COVID-19 enfeksiyonu geçirdikten üç ay sonra saç dökülmesi şikayeti ile başvuran bir olgu sunulmaktadır.

Keywords

• COVID-19
• SARS-CoV-2
• Telogen Effluvium

Telogen Effluvium After COVID-19 Infection: A Case Report

Abstract

Information on the period after COVID-19 infection has not yet been clarified. Every day, a new one is added to the post-COVID-19 symptoms. Hair loss can be seen in the clinical symptoms of many diseases, as well as after the disease has passed. Telogen effluvium (TE) is a condition characterized by widespread hair loss that occurs approximately 3-4 months after a stressor. In this article, a case who applied with the complaint of hair loss three months after suffering from COVID-19 infection is presented.

Keywords

• COVID-19
• SARS-CoV-2
• Telogen Effluvium

References

1. Gathers RC, McMichael AJ. Hair disorders in systemic disease. Dermatological Signs of Internal Disease. 2009; 355–364.
2. Sperling LC. Hair and systematic disease. Dermatol Clin. 2001; 19: 711–726.
3. Malkud S. Telogen effluvium: A review. J Clin Diagn Res. 2015; 9: WE01–3.
4. Kavala M, Turkoglu Z, Can B. Hair and systemic diseases. Med J Goztepe Train Res Hosp. 2013; 26: 128–132.
5. Lv S, Wang L, Zou X, et al. A case of acute telogen effluvium after SARS-CoV-2 infection. CCID. 2021; 14: 385–387.
6. Veraldi S, Vaira F, Raia DD, et al. Telogen effluvium as first clinical presentation of dengue. G Ital Dermatol Venereol. 2017; 152: 184–185.
7. Rebora A, Ciccarese G, Drago F. Postfebrile telogen effluvium: hair fall after Rickettsia conorii infection. G Ital Dermatol Venereol. 2019; 154: 94–95.
8. Xiong Q, Xu M, Li J, et al. Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clin Microbiol Infect. 2021; 27: 89–95.

9. Moreno-Arrones OM, Lobato-Berezo A, Gomez-Zubiaur A, et al. SARS-CoV-2-induced telogen effluvium: a multicentric study. J Eur Acad Dermatol Venereol. 2021; 35: e181–e183.
10. Jose RJ, Manuel A. COVID-19 cytokine storm: the interplay between inflammation and coagulation. Lancet Respir Med. 2020; 8: e46–e47.
11. Olds H, Liu J, Luk K, et al. Telogen effluvium associated with COVID-19 infection. Dermatol Ther. 2021; 34: e14761.
12. Stoehr JR, Choi JN, Colavincenzo M, et al. Off-label use of topical minoxidil in alopecia: A review. Am J Clin Dermatol. 2019; 20: 237–250.